Все публикации

0:04:23

Advancing into 2024 with Capabilities in New Modalities and Expanded Capacity

0:04:14

Wishing You a Joyful Holiday Season and a Happy New Year!

0:03:38

Novel Approaches to Targeted Protein Degradation

0:44:27

Biophysical and Structural Biology Methods Enable Fragment-based Ligand Discovery

1:06:37

Accelerating your viral gene therapies through discovery, optimization and beyond

1:00:49

Empowering small molecule drug discovery by automatic DEL screening

1:07:52

Recent Advances in Peptide Drug Discovery

0:58:26

Screening Methods to Identify RNA-Targeting Small Molecules

0:49:58

Translational Pharmacology of CNS and Metabolic Disorders for Testing New Modality Therapies

0:57:06

Emerging Modalities in Drug Discovery - Dr. Tao Guo

0:46:24

Recent Advances in Library Synthesis to Accelerate Medicinal Chemistry Research - Dr. Yan Xu

0:14:33

Drug Discovery as an Exploration of Chemical Spaces

0:23:11

Discovery of RNA Targeting Small Molecules - Our Toolbox for RNA Drug Discovery

0:30:35

DNA-Encoded Libraries for the Discovery of Small-Molecule Hits

0:09:38

Steve Yang, Co-CEO of WuXi AppTec at Biotech Showcase 2023

0:54:11

Introduction into Fragment Based Drug Discovery

0:52:18

DISCOVERY AND CHARACTERIZATION OF OLIGONUCLEOTIDE THERAPEUTICS

0:55:48

Therapeutic Oligonucleotide Discovery & Development: Development Day 2

1:06:45

Therapeutic Oligonucleotide Discovery & Development: Discovery Day 1

0:02:47

2022 corporate video EN

0:53:44

Affinity Selection Technologies for Hit Finding: Current State of the Art

0:19:50

DDC 2020: Michael Raba, 'Fragment Screening and Biophysical Hit Validation at WuXi AppTec’s HitS'

0:07:11

Dave Madge, 'Target to IND Oncology Platform'

0:51:00

How to Accelerate the Rate Limiting Step in Drug Discovery, Synthesis of Target Molecules